Upnitskiy AA Clinical efficacy of treating chronic heart failure with a combination of spironolactone and trimetazidine // Klinische Effektivität der Therapie der chronischen Herzinsuffizienz mit Kombination von Spironolacton und Trimetazidin Zeitschrift für Gefäßmedizin 2019; 16 (2): 10-22 Volltext (PDF) Summary Übersicht
| ||||||||||||||||||
Abbildung 10: Changes in GFR Evaluation of changes in GFR by CKD-EPI after 6 (ЕРІ_2) and 12 (ЕРІ_3) months of additional spironolactone and trimetazidine combination therapy. |
![]()
Abbildung 10: Changes in GFR
Evaluation of changes in GFR by CKD-EPI after 6 (ЕРІ_2) and 12 (ЕРІ_3) months of additional spironolactone and trimetazidine combination therapy. |